Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis
Stem Cell Reports · 2024
DOI: 10.1016/j.stemcr.2024.04.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2024. Verfasst von Cheng Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Key Laboratory …. Hauptthemen laut MEDLINE: Hepatocytes, Liver Cirrhosis, Chimera, Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Liver disease is a major global health challenge. There is a shortage of liver donors worldwide, and hepatocyte transplantation (HT) may be an effective treatment to overcome this problem. However, the present approaches for generation of hepatocytes are associated with challenges, and interspecies chimera-derived hepatocytes produced by interspecies blastocyst complementation (IBC) may be promising donor hepatocytes because of their more comprehensive hepatic functions. In this study, we isolated mouse hepatocytes from mouse-rat chimeric livers using IBC and found that interspecies chimera-derived hepatocytes exhibited mature hepatic functions in terms of lipid accumulation, glycogen storage, and urea synthesis. Meanwhile, they were more similar to endogenous hepatocytes than hepatocytes derived in vitro. Interspecies chimera-derived hepatocytes could relieve chronic liver fibrosis and reside in the injured liver after transplantation. Our results suggest that interspecies chimera-derived hepatocytes are a potentially reliable source of hepatocytes and can be applied as a therapeutic approach for HT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Key Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Sciences,…
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China.
Förderung
- Chinese Academy of Sciences
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Huang, C., Jiang, H., Dong, J., Jiang, L., Li, J., Xu, J., Cui, T., Wang, L., Li, X., Feng, G., Zhang, Y., Li, T., Li, W., & Zhou, Q. (2024). Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2024.04.006
Vancouver
Huang C, Jiang H, Dong J, Jiang L, Li J, Xu J, et al. Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis. Stem Cell Reports. 2024. doi:10.1016/j.stemcr.2024.04.006
BibTeX
@article{Huang2024,
author = {Huang, Cheng and Jiang, Haiping and Dong, Jingxi and Jiang, Liyuan and Li, Jie and Xu, Jing and Cui, Tongtong and Wang, Leyun and Li, Xin and Feng, Guihai and Zhang, Ying and Li, Tianda and Li, Wei and Zhou, Qi},
title = {Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis},
journal = {Stem Cell Reports},
year = {2024},
doi = {10.1016/j.stemcr.2024.04.006}
}
EUVIMED